Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
CUTR's Cash to Debt is ranked higher than
98% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 2.28 vs. CUTR: No Debt )
Ranked among companies with meaningful Cash to Debt only.
CUTR' s Cash to Debt Range Over the Past 10 Years
Min: N/A  Med: 10000.00 Max: No Debt
Current: No Debt

Warning: Division by zero in /home/gurufocu/public_html/include/common_stock_functions_2.php on line 6679
N/A
No Debt
Equity to Asset 0.66
CUTR's Equity to Asset is ranked higher than
53% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. CUTR: 0.66 )
Ranked among companies with meaningful Equity to Asset only.
CUTR' s Equity to Asset Range Over the Past 10 Years
Min: 0.31  Med: 0.82 Max: 0.87
Current: 0.66
0.31
0.87
Interest Coverage No Debt
CUTR's Interest Coverage is ranked higher than
97% of the 192 Companies
in the Global Medical Devices industry.

( Industry Median: 44.71 vs. CUTR: No Debt )
Ranked among companies with meaningful Interest Coverage only.
CUTR' s Interest Coverage Range Over the Past 10 Years
Min: 9999.99  Med: 10000.00 Max: 9999.99
Current: No Debt
F-Score: 7
Z-Score: 4.85
M-Score: -2.68
WACC vs ROIC
5.10%
-134.20%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) -3.15
CUTR's Operating margin (%) is ranked lower than
57% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 2.61 vs. CUTR: -3.15 )
Ranked among companies with meaningful Operating margin (%) only.
CUTR' s Operating margin (%) Range Over the Past 10 Years
Min: -20.83  Med: -7.94 Max: 9.39
Current: -3.15
-20.83
9.39
Net-margin (%) -2.90
CUTR's Net-margin (%) is ranked lower than
56% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 0.86 vs. CUTR: -2.90 )
Ranked among companies with meaningful Net-margin (%) only.
CUTR' s Net-margin (%) Range Over the Past 10 Years
Min: -32.93  Med: -7.42 Max: 10.33
Current: -2.9
-32.93
10.33
ROE (%) -4.82
CUTR's ROE (%) is ranked lower than
58% of the 299 Companies
in the Global Medical Devices industry.

( Industry Median: 1.05 vs. CUTR: -4.82 )
Ranked among companies with meaningful ROE (%) only.
CUTR' s ROE (%) Range Over the Past 10 Years
Min: -16.6  Med: -6.99 Max: 9.59
Current: -4.82
-16.6
9.59
ROA (%) -3.34
CUTR's ROA (%) is ranked lower than
54% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: -0.34 vs. CUTR: -3.34 )
Ranked among companies with meaningful ROA (%) only.
CUTR' s ROA (%) Range Over the Past 10 Years
Min: -13.66  Med: -5.30 Max: 7.71
Current: -3.34
-13.66
7.71
ROC (Joel Greenblatt) (%) -84.16
CUTR's ROC (Joel Greenblatt) (%) is ranked lower than
68% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 4.07 vs. CUTR: -84.16 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
CUTR' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -1247.08  Med: -223.26 Max: 140.19
Current: -84.16
-1247.08
140.19
Revenue Growth (3Y)(%) 7.40
CUTR's Revenue Growth (3Y)(%) is ranked higher than
64% of the 236 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. CUTR: 7.40 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
CUTR' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -18.1  Med: 9.50 Max: 54.9
Current: 7.4
-18.1
54.9
EBITDA Growth (3Y)(%) -13.60
CUTR's EBITDA Growth (3Y)(%) is ranked lower than
76% of the 201 Companies
in the Global Medical Devices industry.

( Industry Median: 1.90 vs. CUTR: -13.60 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
CUTR' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -29  Med: 17.35 Max: 88.4
Current: -13.6
-29
88.4
EPS Growth (3Y)(%) -11.90
CUTR's EPS Growth (3Y)(%) is ranked lower than
67% of the 203 Companies
in the Global Medical Devices industry.

( Industry Median: 2.60 vs. CUTR: -11.90 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
CUTR' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -29.6  Med: 20.35 Max: 144.8
Current: -11.9
-29.6
144.8
» CUTR's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-08-05)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

CUTR Guru Trades in Q2 2015

Jim Simons 929,570 sh (+14.18%)
Mario Gabelli 635,000 sh (unchged)
» More
Q3 2015

CUTR Guru Trades in Q3 2015

Jim Simons 918,400 sh (-1.20%)
Mario Gabelli 605,000 sh (-4.72%)
» More
Q4 2015

CUTR Guru Trades in Q4 2015

Jim Simons 993,831 sh (+8.21%)
Mario Gabelli 605,000 sh (unchged)
» More
Q1 2016

CUTR Guru Trades in Q1 2016

Jim Simons 1,074,900 sh (+8.16%)
Mario Gabelli 605,000 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with CUTR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices
Compare:OTCPK:XVIPF, NAS:IRIX, OTCPK:LFWWF, NAS:AVGR, AMEX:CVRS, NAS:EYES, OTCPK:SOMNF, NAS:ACRX, NAS:FONR, NYSE:GI, NAS:SURG, NAS:TRIV, OTCPK:DMTRF, NAS:AXGN, NAS:SPNE, NAS:VRAY, NAS:DRAD, OTCPK:BIQLF, OTCPK:TITXF, OTCPK:ELXMF » details
Traded in other countries:TJ9.Germany,
Cutera Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy based aesthetics systems for practitioners.

Cutera Inc was established in the San Francisco Bay Area in 1998. It is a medical device company, specializing in the design, development, manufacture, marketing and servicing of laser and other energy based aesthetics systems for practitioners. It offers easy-to-use products based on four main platforms/systems Xeo, GenesisPlus, ExcelV, and truSculpt, each of which enables physicians and other qualified practitioners to perform safe and effective aesthetic procedures for their customers. The Xeo is a multi-application platform on which a customer can purchase hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin rejuvenation by treating discoloration, improving texture, reducing pore size, and treating fine lines and laxity. GenesisPlus platform, is a dedicated laser system for performing aesthetic skin procedures and for the temporary increase of clear nail in patients with onychomycosis, or toenail fungus. ExcelV is a high-performance, vascular platform designed specifically for the core-market of Dermatologists and Plastic Surgeons. This platform provides a combination of the 532 nm green laser with Cutera's award-winning 1064 nm Nd:YAG technology, to provide a single, compact and efficient system that treats the entire range of cosmetic vascular conditions, without the need for costly consumables. truSculpt is a high-powered radio frequency platform designed for the non-invasive body contouring market. This system is designed to treat all body areas and with its electrode design is able to achieve comfortable, uniform heating of the subcutaneous fat. In the U.S. its markets and sells its products mainly through a direct sales organization. International sales are generally made through a distributor network in over 60 countries. As of December 31, 2013, the Company had 30 issued U.S. patents and 11 pending U.S. patent applications. Its registered trademarks include Cutera, Acutip 500, CoolGlide, CoolGlide Excel, Limelight, myQ, Pearl, ProWave 770, ProWave LX, Solera, Titan, Xeo and truSculpt. The Company's products competes against laser and other energy-based products offered by public companies, such as Cynosure, Elen (in Italy), Lumenis, Syneron and Zeltiq, as well as private companies, including, Alma, Sciton, and several others. Its products are medical devices subject to extensive and rigorous regulation by the U.S. Food and Drug Administration, as well as other regulatory bodies.

Ratios

vs
industry
vs
history
Forward P/E 31.06
CUTR's Forward P/E is ranked lower than
70% of the 54 Companies
in the Global Medical Devices industry.

( Industry Median: 23.53 vs. CUTR: 31.06 )
Ranked among companies with meaningful Forward P/E only.
N/A
P/B 2.81
CUTR's P/B is ranked higher than
50% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 2.92 vs. CUTR: 2.81 )
Ranked among companies with meaningful P/B only.
CUTR' s P/B Range Over the Past 10 Years
Min: 0.68  Med: 1.58 Max: 5.4
Current: 2.81
0.68
5.4
P/S 1.49
CUTR's P/S is ranked higher than
68% of the 293 Companies
in the Global Medical Devices industry.

( Industry Median: 3.07 vs. CUTR: 1.49 )
Ranked among companies with meaningful P/S only.
CUTR' s P/S Range Over the Past 10 Years
Min: 0.93  Med: 2.01 Max: 7.7
Current: 1.49
0.93
7.7
POCF 531.00
CUTR's POCF is ranked lower than
100% of the 130 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. CUTR: 531.00 )
Ranked among companies with meaningful POCF only.
CUTR' s POCF Range Over the Past 10 Years
Min: 8.11  Med: 30.16 Max: 633
Current: 531
8.11
633
Current Ratio 3.16
CUTR's Current Ratio is ranked higher than
56% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 2.86 vs. CUTR: 3.16 )
Ranked among companies with meaningful Current Ratio only.
CUTR' s Current Ratio Range Over the Past 10 Years
Min: 2.5  Med: 6.74 Max: 9.09
Current: 3.16
2.5
9.09
Quick Ratio 2.56
CUTR's Quick Ratio is ranked higher than
59% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 2.07 vs. CUTR: 2.56 )
Ranked among companies with meaningful Quick Ratio only.
CUTR' s Quick Ratio Range Over the Past 10 Years
Min: 2.21  Med: 6.24 Max: 8.66
Current: 2.56
2.21
8.66
Days Inventory 113.64
CUTR's Days Inventory is ranked higher than
59% of the 284 Companies
in the Global Medical Devices industry.

( Industry Median: 136.99 vs. CUTR: 113.64 )
Ranked among companies with meaningful Days Inventory only.
CUTR' s Days Inventory Range Over the Past 10 Years
Min: 63.96  Med: 104.48 Max: 137.01
Current: 113.64
63.96
137.01
Days Sales Outstanding 41.55
CUTR's Days Sales Outstanding is ranked higher than
87% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 68.64 vs. CUTR: 41.55 )
Ranked among companies with meaningful Days Sales Outstanding only.
CUTR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 22.62  Med: 36.58 Max: 52.02
Current: 41.55
22.62
52.02
Days Payable 22.67
CUTR's Days Payable is ranked lower than
88% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 61.70 vs. CUTR: 22.67 )
Ranked among companies with meaningful Days Payable only.
CUTR' s Days Payable Range Over the Past 10 Years
Min: 17.66  Med: 21.02 Max: 36.15
Current: 22.67
17.66
36.15

Valuation & Return

vs
industry
vs
history
Price/Net Cash 7.34
CUTR's Price/Net Cash is ranked higher than
70% of the 115 Companies
in the Global Medical Devices industry.

( Industry Median: 16.61 vs. CUTR: 7.34 )
Ranked among companies with meaningful Price/Net Cash only.
CUTR' s Price/Net Cash Range Over the Past 10 Years
Min: 1.2  Med: 2.56 Max: 8.12
Current: 7.34
1.2
8.12
Price/Net Current Asset Value 3.09
CUTR's Price/Net Current Asset Value is ranked higher than
76% of the 217 Companies
in the Global Medical Devices industry.

( Industry Median: 6.73 vs. CUTR: 3.09 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
CUTR' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 0.91  Med: 1.92 Max: 23.73
Current: 3.09
0.91
23.73
Price/Tangible Book 2.95
CUTR's Price/Tangible Book is ranked higher than
61% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 3.64 vs. CUTR: 2.95 )
Ranked among companies with meaningful Price/Tangible Book only.
CUTR' s Price/Tangible Book Range Over the Past 10 Years
Min: 0.77  Med: 1.86 Max: 20.68
Current: 2.95
0.77
20.68
Price/Median PS Value 0.76
CUTR's Price/Median PS Value is ranked higher than
73% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 1.03 vs. CUTR: 0.76 )
Ranked among companies with meaningful Price/Median PS Value only.
CUTR' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.54  Med: 1.05 Max: 2.54
Current: 0.76
0.54
2.54
Earnings Yield (Greenblatt) (%) -3.30
CUTR's Earnings Yield (Greenblatt) (%) is ranked lower than
59% of the 315 Companies
in the Global Medical Devices industry.

( Industry Median: 0.70 vs. CUTR: -3.30 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
CUTR' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -3.27  Med: 6.60 Max: 795.7
Current: -3.3
-3.27
795.7

More Statistics

Revenue (TTM) (Mil) $98.11
EPS (TTM) $ -0.20
Beta0.47
Short Percentage of Float3.44%
52-Week Range $9.83 - 16.37
Shares Outstanding (Mil)13.08

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 105 114 123
EPS ($) 0.35 0.45 0.60
EPS w/o NRI ($) 0.35 0.45 0.60
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
» More Articles for CUTR

Headlines

Articles On GuruFocus.com
Chuck Royce's Top Five Second Quarter Portfolio Increases Aug 07 2013 
Gurus Buy Micro Caps – Bamboo Toilet Paper Jul 24 2013 
Guru Weekly Real Time Update Jul 05 2013 
Mario Gabelli and Jean-Marie Eveillard's Real Time Increases Jul 02 2013 
Weekly CFO Sells Highlight: MSCC, BMRN, VAL, CUTR, REX, CIEN Oct 02 2011 

More From Other Websites
CUTERA INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 15 2016
ETF’s with exposure to Cutera, Inc. : June 3, 2016 Jun 03 2016
Cutera, Inc. :CUTR-US: Earnings Analysis: Q1, 2016 By the Numbers : May 23, 2016 May 23 2016
CUTERA INC Financials May 07 2016
Cutera reports 1Q loss May 02 2016
Cutera reports 1Q loss May 02 2016
Cutera Inc Earnings Call scheduled for 5:00 pm ET today May 02 2016
Cutera, Inc. to Announce Results for the First Quarter Ended March 31, 2016 May 02 2016
CUTERA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... May 02 2016
CUTERA INC Files SEC form 10-Q, Quarterly Report May 02 2016
Cutera Reports First Quarter 2016 Results May 02 2016
Q1 2016 Cutera Inc Earnings Release - After Market Close May 02 2016
Cutera Obtains Japanese Regulatory Clearance for enlighten™ Apr 19 2016
Cutera, Inc. to Announce Results for the First Quarter Ended March 31, 2016 Apr 19 2016
Cutera (CUTR): Strong Industry, Solid Earnings Estimate Revisions Apr 06 2016
ETF’s with exposure to Cutera, Inc. : March 31, 2016 Mar 31 2016
Cutera Obtains Japanese Regulatory Clearance for enlighten™ Mar 31 2016
Cutera (CUTR) Sees Hammer Chart Pattern: Time to Buy? Mar 29 2016
Cutera, Inc. :CUTR-US: Earnings Analysis: Q4, 2015 By the Numbers Mar 21 2016
CUTERA INC Files SEC form 10-K, Annual Report Mar 15 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)